GSK CEO Admits Executives Deceived Chinese Officials, Company Brass

Certain senior managers in the Chinese arm of GlaxoSmithKline “acted outside of the company’s processes and controls to defraud the company and Chinese officials,” GSK Chief Executive Officer Andrew Witty said Wednesday, addressing questions about the company’s brewing bribery scandal.
Drug Industry Daily